Grifols reports Q2 revenue EUR 1.89B vs. EUR 1.79B last quarter

Reports Q2 profit EUR 191M vs. EUR 115M last quarter. The company said, “The company’s strong performance in the first six months of 2025 reflects the solid execution of our Value Creation Plan. The momentum of the business is clear: in a context of strong underlying demand, we continue to capitalize on the strength of our Biopharma business unit while advancing on key priorities.”